Propionic Acid

Propionic Acid

SCHEMBL4153298

CCC(=O)O.Cc1nc(-c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)cs1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.45
RAB9A P51151 6/20 0.42
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
BRD4 O60885 1/20 0.41
ROCK2 O75116 1/20 0.41
PIM1 P11309 1/20 0.41
GSK3B P49841 1/20 0.41
AURKB Q96GD4 1/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 2/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
RECQL P46063 2/20 0.40
ESR2 Q92731 1/20 0.40
MMP12 P39900 1/20 0.38
P2RX7 Q99572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4155444 0.90 PARP1 (0.43) PARP1RAB9ANPC1SMN1; SMN2ROCK2
Propionic Acid SCHEMBL4155352 0.87 SMN1; SMN2 (0.48) RAB9ANPC1SMN1; SMN2GAAKDM4E
Propionic Acid SCHEMBL4164428 0.84 CSNK2A1 (0.48) RAB9ANPC1SMN1; SMN2ROCK2PIM1
Propionic Acid SCHEMBL4160653 0.83 CSNK2A1 (0.39) PARP1RAB9ANPC1SMN1; SMN2ROCK2
Propionic Acid SCHEMBL4157999 0.83 ABL1 (0.52) PARP1RAB9ANPC1SMN1; SMN2GAA
Propionic Acid SCHEMBL4158054 0.82 CFTR (0.39) PARP1RAB9ANPC1SMN1; SMN2ROCK2
Propionic Acid SCHEMBL4159319 0.82 HDAC3 (0.48) PARP1RAB9ANPC1ALDH1A1MAPT
Propionic Acid SCHEMBL4163705 0.82 BAZ2A (0.42) PARP1SMN1; SMN2GSK3BALDH1A1
Propionic Acid SCHEMBL4153840 0.81 PIM1 (0.44) NPC1PIM1GSK3BKDM4EALDH1A1
Propionic Acid SCHEMBL4167038 0.81 ALOX5 (0.47) RAB9ASMN1; SMN2GAAKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PARP1 628/4885RAB9A 2269/4885NPC1 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.